Atlas Trials

Enzalutamide Treatment in COVID-19

Clinical trial NCT04475601 · TERMINATED

Trial details

NCT number
NCT04475601
Sponsor
Andreas Josefsson
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19Corona Virus Infection
Start date
2020-07-15
Primary completion
2021-03-24
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.